Skip to content
Pharma Observatory a Scientist.com platform

Organization (Hospital)

Fondazione Poliambulanza Istituto Ospedaliero

ClinicalTrials.gov lists Fondazione Poliambulanza Istituto Ospedaliero as lead sponsor of 19 trials. It has 1 approved asset.

IT Hospital
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

5 0 1997 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Fondazione Poliambulanza Istituto Ospedaliero: 19 lead-sponsored trials and 1 legal-entity registration.

Get the Fondazione Poliambulanza Istituto Ospedaliero report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (37)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Colorectal Neoplasms 3
Colonic Neoplasms 2
Colonic Polyps 2
Liver Neoplasms 2
Polyps 2

Trials by start year as sponsor or collaborator (13)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2025 2
2024 1
2023 2
2022 1
2021 5
2020 4
2019 1
2018 4
2017 1
2016 1

Recruitment duration, a model prediction: none of the 19 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (1)

Approved assets
Drug Trials
Remifentanil 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
67% hit target (n=6) 20% on time (n=5)

Journals published in (99)

Shown in this order: most published in first.

Journals published in
Journal Publications
Lancet (London, England) 6
Acta paediatrica (Oslo, Norway : 1992) 5
The New England journal of medicine 5
Pediatrics 4
Archives of disease in childhood. Fetal and neonatal edition 3

Organization relationships (14)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Fondazione Policlinico Universitario Agostino Gemelli IRCCS Co sponsors trial with 2
Endo-Kapszula Magánorvosi Centrum Co sponsors trial with 1
Vittore Buzzi Children's Hospital Co sponsors trial with 1
Saint Antoine University Hospital Co sponsors trial with 1
South Tyneside and Sunderland NHS Foundation Trust Co sponsors trial with 1

Latest dated events (27)

Shown in this order: newest first.

Latest dated events
Date Event Source
2025-07-21 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-03-03 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-12-13 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarkers this organization publishes on (115)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
CD8A 3
EGFR 3
IL5 3
TNF 3
CD4 2

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.